doi: 10.2131/jts.32.449.
Methylenetetrahydrofolate reductase and reduced folate carrier-1 genotypes and methotrexate serum concentrations in patients with rheumatoid arthritis
Affiliations
- PMID: 17965559
- DOI: 10.2131/jts.32.449
Item in Clipboard
Methylenetetrahydrofolate reductase and reduced folate carrier-1 genotypes and methotrexate serum concentrations in patients with rheumatoid arthritis
J Toxicol Sci.
2007 Oct.
Free article
Abstract
We investigated the genotypes of methylenetetrahydrofolate reductase (MTHFR) and reduced folate carrier-1 (RFC-1), and the serum concentrations of methotrexate (MTX) in 100 outpatients with rheumatoid arthritis (RA). Frequencies of MTHFR C677T and A1298C were similar to those reported in Japanese RA patients, while frequencies of RFC-1 G80A genotypes differed from those reported in RA patients in the United States. No correlations were found between these genotypes and serum MTX levels.
Similar articles
-
Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.OMICS. 2012 Nov;16(11):589-95. doi: 10.1089/omi.2011.0142. Epub 2012 Oct 24. OMICS. 2012. PMID: 23095111
-
Polymorphisms C677T and A1298C in the MTHFR gene in Mexican patients with rheumatoid arthritis treated with methotrexate: implication with elevation of transaminases.Pharmacogenomics J. 2011 Aug;11(4):287-91. doi: 10.1038/tpj.2010.32. Epub 2010 Jun 1. Pharmacogenomics J. 2011. PMID: 20514079
-
Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.Arthritis Rheum. 2006 Apr;54(4):1087-95. doi: 10.1002/art.21726. Arthritis Rheum. 2006. PMID: 16572443
-
[Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience].Reumatismo. 2009 Apr-Jun;61(2):98-106. doi: 10.4081/reumatismo.2009.98. Reumatismo. 2009. PMID: 19633796 Review. Italian.
-
Associations between the C677T and A1298C polymorphisms of MTHFR and the efficacy and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.Clin Drug Investig. 2010;30(2):101-8. doi: 10.2165/11531070-000000000-00000. Clin Drug Investig. 2010. PMID: 20067328 Review.
Cited by
-
Pharmacogenomics of Methotrexate Pathway in Rheumatoid Arthritis Patients: Approach toward Personalized Medicine.Diagnostics (Basel). 2022 Jun 27;12(7):1560. doi: 10.3390/diagnostics12071560. Diagnostics (Basel). 2022. PMID: 35885466 Free PMC article.
-
Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients.Pharmacogenomics J. 2013 Jun;13(3):227-34. doi: 10.1038/tpj.2012.7. Epub 2012 Mar 27. Pharmacogenomics J. 2013. PMID: 22450926 Free PMC article.
-
MTRR A66G, RFC1 G80A, and MTHFR C677T and A1298C Polymorphisms and Disease Activity in Mexicans with Rheumatoid Arthritis Treated with Methotrexate.Genet Test Mol Biomarkers. 2017 Nov;21(11):698-704. doi: 10.1089/gtmb.2017.0124. Epub 2017 Oct 10. Genet Test Mol Biomarkers. 2017. PMID: 28994615 Free PMC article.
-
Evaluation of cytogenetic and molecular markers with MTX-mediated toxicity in pediatric acute lymphoblastic leukemia patients.Cancer Chemother Pharmacol. 2022 Mar;89(3):393-400. doi: 10.1007/s00280-022-04405-7. Epub 2022 Feb 14. Cancer Chemother Pharmacol. 2022. PMID: 35157101
-
Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population.J Pharm Health Care Sci. 2016 Dec 9;2:35. doi: 10.1186/s40780-016-0069-0. eCollection 2016. J Pharm Health Care Sci. 2016. PMID: 27980801 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
